vs
美国运通（AXP）与礼来（RNA）财务数据对比。点击上方公司名可切换其他公司
美国运通的季度营收约是礼来的1.5倍（$18.9M vs $12.5M），美国运通净利率更高（15.7% vs -1398.3%，领先1414.0%），礼来同比增速更快（434.0% vs 11.4%），过去两年礼来的营收复合增速更高（138.5% vs -95.6%）
美国运通是全球知名的支付服务提供商，主营签账卡、信用卡产品及旅行相关服务，下设全球消费者服务、全球商业服务、全球商户与网络服务三大业务板块，还提供支付融资、网络服务、应付账款费用管理、旅行生活服务等多元解决方案。
礼来是总部位于美国印第安纳州印第安纳波利斯的跨国制药企业，在18个国家设有办事处，产品销往全球约125个国家。公司由美国内战时期联邦军退伍军人、药剂师伊莱·礼来于1876年创立，品牌名即取自创始人姓名。
AXP vs RNA — 直观对比
营收规模更大
AXP
是对方的1.5倍
$12.5M
营收增速更快
RNA
高出422.6%
11.4%
净利率更高
AXP
高出1414.0%
-1398.3%
两年增速更快
RNA
近两年复合增速
-95.6%
损益表 — Q1 FY2026 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $18.9M | $12.5M |
| 净利润 | $3.0M | $-174.4M |
| 毛利率 | — | — |
| 营业利润率 | — | -1513.5% |
| 净利率 | 15.7% | -1398.3% |
| 营收同比 | 11.4% | 434.0% |
| 净利润同比 | 15.0% | -117.0% |
| 每股收益（稀释后） | — | $-1.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AXPRNA
| Q1 26 | $18.9M | — | ||
| Q4 25 | $10.9B | — | ||
| Q3 25 | $10.4B | $12.5M | ||
| Q2 25 | $10.3B | $3.8M | ||
| Q1 25 | $9.6B | $1.6M | ||
| Q4 24 | $10.0B | $3.0M | ||
| Q3 24 | $9.7B | $2.3M | ||
| Q2 24 | $9.8B | $2.0M |
净利润AXPRNA
| Q1 26 | $3.0M | — | ||
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.9B | $-174.4M | ||
| Q2 25 | $2.9B | $-157.3M | ||
| Q1 25 | $2.6B | $-115.8M | ||
| Q4 24 | $2.2B | $-102.3M | ||
| Q3 24 | $2.5B | $-80.4M | ||
| Q2 24 | $3.0B | $-70.8M |
营业利润率AXPRNA
| Q1 26 | — | — | ||
| Q4 25 | 28.2% | — | ||
| Q3 25 | 36.7% | -1513.5% | ||
| Q2 25 | 34.4% | -4448.7% | ||
| Q1 25 | 34.6% | -8360.9% | ||
| Q4 24 | 27.7% | -4069.6% | ||
| Q3 24 | 33.0% | -4200.9% | ||
| Q2 24 | 38.6% | -4040.4% |
净利率AXPRNA
| Q1 26 | 15.7% | — | ||
| Q4 25 | 22.5% | — | ||
| Q3 25 | 27.9% | -1398.3% | ||
| Q2 25 | 28.0% | -4089.3% | ||
| Q1 25 | 26.8% | -7360.0% | ||
| Q4 24 | 21.8% | -3439.5% | ||
| Q3 24 | 25.8% | -3441.7% | ||
| Q2 24 | 30.7% | -3461.8% |
每股收益（稀释后）AXPRNA
| Q1 26 | — | — | ||
| Q4 25 | $3.52 | — | ||
| Q3 25 | $4.14 | $-1.27 | ||
| Q2 25 | $4.08 | $-1.21 | ||
| Q1 25 | $3.64 | $-0.90 | ||
| Q4 24 | $3.04 | $-0.80 | ||
| Q3 24 | $3.49 | $-0.65 | ||
| Q2 24 | $4.15 | $-0.65 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $350.2M |
| 总债务越低越好 | $60.4M | — |
| 股东权益账面价值 | $34.0M | $1.9B |
| 总资产 | $308.9M | $2.1B |
| 负债/权益比越低杠杆越低 | 1.78× | — |
8季度趋势，按日历期对齐
现金及短期投资AXPRNA
| Q1 26 | — | — | ||
| Q4 25 | $742.0M | — | ||
| Q3 25 | $1.3B | $350.2M | ||
| Q2 25 | $197.0M | $243.9M | ||
| Q1 25 | $261.0M | $254.2M | ||
| Q4 24 | $221.0M | $219.9M | ||
| Q3 24 | $120.0M | $370.2M | ||
| Q2 24 | $188.0M | $575.8M |
总债务AXPRNA
| Q1 26 | $60.4M | — | ||
| Q4 25 | $56.4B | — | ||
| Q3 25 | $57.8B | — | ||
| Q2 25 | $58.2B | — | ||
| Q1 25 | $51.2B | — | ||
| Q4 24 | $49.7B | — | ||
| Q3 24 | $53.5B | — | ||
| Q2 24 | $51.5B | — |
股东权益AXPRNA
| Q1 26 | $34.0M | — | ||
| Q4 25 | $33.5B | — | ||
| Q3 25 | $32.4B | $1.9B | ||
| Q2 25 | $32.3B | $1.2B | ||
| Q1 25 | $31.2B | $1.3B | ||
| Q4 24 | $30.3B | $1.4B | ||
| Q3 24 | $29.7B | $1.5B | ||
| Q2 24 | $29.5B | $1.2B |
总资产AXPRNA
| Q1 26 | $308.9M | — | ||
| Q4 25 | $300.1B | — | ||
| Q3 25 | $297.6B | $2.1B | ||
| Q2 25 | $295.6B | $1.4B | ||
| Q1 25 | $282.2B | $1.5B | ||
| Q4 24 | $271.5B | $1.6B | ||
| Q3 24 | $271.0B | $1.6B | ||
| Q2 24 | $272.2B | $1.3B |
负债/权益比AXPRNA
| Q1 26 | 1.78× | — | ||
| Q4 25 | 1.68× | — | ||
| Q3 25 | 1.78× | — | ||
| Q2 25 | 1.80× | — | ||
| Q1 25 | 1.64× | — | ||
| Q4 24 | 1.64× | — | ||
| Q3 24 | 1.80× | — | ||
| Q2 24 | 1.74× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-156.2M |
| 自由现金流经营现金流 - 资本支出 | — | $-156.9M |
| 自由现金流率自由现金流/营收 | — | -1257.6% |
| 资本支出强度资本支出/营收 | — | 5.7% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-592.3M |
8季度趋势，按日历期对齐
经营现金流AXPRNA
| Q1 26 | — | — | ||
| Q4 25 | $3.1B | — | ||
| Q3 25 | $6.2B | $-156.2M | ||
| Q2 25 | $4.4B | $-199.7M | ||
| Q1 25 | $4.8B | $-124.8M | ||
| Q4 24 | $5.8B | $-99.9M | ||
| Q3 24 | $-1.8B | $-65.6M | ||
| Q2 24 | $4.5B | $-65.0M |
自由现金流AXPRNA
| Q1 26 | — | — | ||
| Q4 25 | $2.3B | — | ||
| Q3 25 | $5.6B | $-156.9M | ||
| Q2 25 | $3.7B | $-203.0M | ||
| Q1 25 | $4.3B | $-128.6M | ||
| Q4 24 | $5.3B | $-103.8M | ||
| Q3 24 | $-2.3B | $-67.3M | ||
| Q2 24 | $4.0B | $-65.5M |
自由现金流率AXPRNA
| Q1 26 | — | — | ||
| Q4 25 | 21.4% | — | ||
| Q3 25 | 53.6% | -1257.6% | ||
| Q2 25 | 36.3% | -5277.1% | ||
| Q1 25 | 45.0% | -8174.3% | ||
| Q4 24 | 53.1% | -3491.0% | ||
| Q3 24 | -23.3% | -2881.8% | ||
| Q2 24 | 40.4% | -3204.6% |
资本支出强度AXPRNA
| Q1 26 | — | — | ||
| Q4 25 | 6.6% | — | ||
| Q3 25 | 6.3% | 5.7% | ||
| Q2 25 | 6.0% | 86.9% | ||
| Q1 25 | 4.5% | 238.6% | ||
| Q4 24 | 5.0% | 131.7% | ||
| Q3 24 | 4.7% | 72.9% | ||
| Q2 24 | 5.8% | 26.0% |
现金转化率AXPRNA
| Q1 26 | — | — | ||
| Q4 25 | 1.25× | — | ||
| Q3 25 | 2.15× | — | ||
| Q2 25 | 1.51× | — | ||
| Q1 25 | 1.84× | — | ||
| Q4 24 | 2.66× | — | ||
| Q3 24 | -0.72× | — | ||
| Q2 24 | 1.50× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AXP
| Discount revenue | $9.5M | 50% |
| Other | $8.9M | 47% |
| Deposits with banks and other | $512.0K | 3% |
RNA
暂无分部数据
